This Month’s Issue of JUO

Abstract

Prostate cancer is a severe health problem worldwide, and timely and accurate diagnosis is essential for effective treatment planning. In recent years, multiparametric magnetic resonance imaging (mpMRI) has emerged as a powerful noninvasive tool in detecting and characterizing prostate cancer. The clinical application of mpMRI has changed the diagnostic landscape, allowing for improved risk stratification and guided targeted biopsies. Professor Chang Wook Jeong [1] contributed a review article that provides a comprehensive analysis of the use of magnetic resonance imaging (MRI) and fusion biopsy in the context of active surveillance for prostate cancer. Professor Byung Kwan Park [2] drew on his extensive experience to point out the limitations of the current PI-RADS (Prostate Imaging and Reporting and Data System) version 2.1. Professors Jun Nyung Lee and Tae Gyun Kwon [3] authored an original paper presenting an innovative study on the importance of multivariate MRI in predicting extraprostatic extension in prostate cancer patients. Finally, Professor Kyung Kgi Park [4] offers a cost-benefit comparison of biparametric MRI in a study highlighting the economic implications of using this imaging modality in evaluating prostate cancer.